Literature DB >> 2197584

[Breast cancer in the male--a retrospective analysis of 15 cases].

M Stierer1, H Spoula, H R Rosen.   

Abstract

We report about 15 cases of cancer of the male breast treated within the period 1972-1988 at the Surgical Department of the Hanusch-Krankenhaus, Vienna. Patients age ranged from 38 to 82 years, averaging 61.7 years. After a median follow-up period of 40 months (ranging from 1-171 months) two-thirds of our patients had died, 40% from the primary disease. In cases with a follow-up period of more than 5 years, only 1 out of 11 patients is still alive, 6 of them having died in the meantime. In 40% of our patients the first symptom noticed was a painful lump accompanied by gynecomastia. Seven patients out of 15 (i.e. 46.6%) had been treated previously with aldosterone antagonists of spironolactone type. Except for 1 patient who had had X-ray radiation in the past, no other exposure to possible risks could be observed. A multicentre data input and central processing of generic data for the evaluation of optimal treatment of this rare disease is desirable.

Entities:  

Mesh:

Year:  1990        PMID: 2197584     DOI: 10.1159/000216739

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  2 in total

1.  Spironolactone use and risk of incident cancers: a retrospective, matched cohort study.

Authors:  Isla S Mackenzie; Steven V Morant; Li Wei; Alastair M Thompson; Thomas M MacDonald
Journal:  Br J Clin Pharmacol       Date:  2016-11-12       Impact factor: 4.335

2.  Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study.

Authors:  Isla S Mackenzie; Thomas M Macdonald; Alastair Thompson; Steve Morant; Li Wei
Journal:  BMJ       Date:  2012-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.